The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prescribing patterns for FOLFIRINOX in the real world.
 
Chad Michael Guenther
No Relationships to Disclose
 
Nizar Bhulani
No Relationships to Disclose
 
Adam Korenke
No Relationships to Disclose
 
Jenny Jing Li
No Relationships to Disclose
 
Leticia Khosama
No Relationships to Disclose
 
Samira K. Syed
No Relationships to Disclose
 
Syed Mohammad Ali Kazmi
No Relationships to Disclose
 
Naga Koteswari Cheedella
No Relationships to Disclose
 
Sirisha Karri
No Relationships to Disclose
 
Jay Lohrey
No Relationships to Disclose
 
Aravind Sanjeevaiah
Consulting or Advisory Role - Guardant Health
 
Udit N. Verma
No Relationships to Disclose
 
John Vernon Cox
Employment - Texas Oncology; University of Texas Southwestern Medical Center - Simmons Cancer Center
Leadership - Parkland Health System; Texas Oncology
Stock and Other Ownership Interests - Amgen; Medfusion; Merck; Pfizer
Research Funding - US Oncology
Other Relationship - American Society of Clinical Oncology; Mary Crowley Research Center, Dallas Texas; Methodist Health System Dallas Texas
 
Yull Edwin Arriaga
No Relationships to Disclose
 
Muhammad Shaalan Beg
Honoraria - Bristol-Myers Squibb; Genentech/Roche
Consulting or Advisory Role - Celgene; Genentech/Roche; Guardant Health; Ipsen; Merrimack
Speakers' Bureau - Ipsen
Research Funding - Agios (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck Serono (Inst)